Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
The Journal of Urology
|
June 7, 2006
Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma
Bulent Akdogan, Hasan Serkan Dogan, Saadettin Yilmaz Eskicorapci, et al.
The Journal of Urology
|
April 12, 2005
Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection
Saadettin Yilmaz Eskicorapci, Fuad Guliyev, Bulent Akdogan, et al.
Journal of the National Medical Association
|
August 10, 2006
Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancer
Fadil Akyol, Ugur Selek, Gokhan Ozyigit, et al.
Urologia
|
January 9, 2016
Predictors of prostate cancer in ultrasound-guided transperineal saturation biopsy in Turkish men with multiple prior negative biopsies
Sertac Yazici, Halil Kiziloz, Ali Cansu Bozaci, et al.
Croatian Medical Journal
|
November 3, 2021
The SPARE score reliably predicts the conversion from open partial to radical nephrectomy
Hakan Bahadır Haberal, Burak Citamak, Mesut Altan, et al.
Sisli Etfal Hastanesi Tip Bulteni
|
August 22, 2022
Impact of Variant Histology on Clinical and Pathological Outcomes in Patients with the Upper Urinary Tract Urothelial Carcinoma
Meylis Artykov, Hakan Bahadır Haberal, Mesut Altan, et al.
European Urology
|
March 26, 2004
An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer
Saadettin Yilmaz Eskicorapci, Dilek Ertoy Baydar, Cem Akbal, et al.
Urologic Oncology
|
November 15, 2020
Gemcitabine based trimodality treatment in patients with muscle invasive bladder cancer: May neutrophil lymphocyte and platelet lymphocyte ratios predict outcomes?
Pervin Hurmuz, Gokhan Ozyigit, Saddettin Kilickap, et al.
Clinical Biochemistry
|
January 21, 2006
Serum ribonuclease activity in the diagnosis of prostate cancer in men with serum prostate-specific antigen levels between 2.5 and 20 ng/mL
Saadettin Yilmaz Eskicorapci, H Asuman Ozkara, Evren Onder, et al.
European Urology
|
February 18, 2005
Can we obtain better specimens with an end-cutting prostatic biopsy device?
Hasan Serkan Dogan, Saadettin Yilmaz Eskicorapci, Dilek Ertoy-Baydar, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
The Journal of Urology
|
June 7, 2006
Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma
Bulent Akdogan, Hasan Serkan Dogan, Saadettin Yilmaz Eskicorapci, et al.
The Journal of Urology
|
April 12, 2005
Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection
Saadettin Yilmaz Eskicorapci, Fuad Guliyev, Bulent Akdogan, et al.
Journal of the National Medical Association
|
August 10, 2006
Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancer
Fadil Akyol, Ugur Selek, Gokhan Ozyigit, et al.
Urologia
|
January 9, 2016
Predictors of prostate cancer in ultrasound-guided transperineal saturation biopsy in Turkish men with multiple prior negative biopsies
Sertac Yazici, Halil Kiziloz, Ali Cansu Bozaci, et al.
Croatian Medical Journal
|
November 3, 2021
The SPARE score reliably predicts the conversion from open partial to radical nephrectomy
Hakan Bahadır Haberal, Burak Citamak, Mesut Altan, et al.
Sisli Etfal Hastanesi Tip Bulteni
|
August 22, 2022
Impact of Variant Histology on Clinical and Pathological Outcomes in Patients with the Upper Urinary Tract Urothelial Carcinoma
Meylis Artykov, Hakan Bahadır Haberal, Mesut Altan, et al.
European Urology
|
March 26, 2004
An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer
Saadettin Yilmaz Eskicorapci, Dilek Ertoy Baydar, Cem Akbal, et al.
Urologic Oncology
|
November 15, 2020
Gemcitabine based trimodality treatment in patients with muscle invasive bladder cancer: May neutrophil lymphocyte and platelet lymphocyte ratios predict outcomes?
Pervin Hurmuz, Gokhan Ozyigit, Saddettin Kilickap, et al.
Clinical Biochemistry
|
January 21, 2006
Serum ribonuclease activity in the diagnosis of prostate cancer in men with serum prostate-specific antigen levels between 2.5 and 20 ng/mL
Saadettin Yilmaz Eskicorapci, H Asuman Ozkara, Evren Onder, et al.
European Urology
|
February 18, 2005
Can we obtain better specimens with an end-cutting prostatic biopsy device?
Hasan Serkan Dogan, Saadettin Yilmaz Eskicorapci, Dilek Ertoy-Baydar, et al.
Page
of 8